<?xml version="1.0" encoding="UTF-8"?>
<p>Baicalin has also shown some efficacy in neuropathic pain: an 
 <italic>in vivo</italic> study on spinal nerve ligation rats showed that tactile allodynia and thermal hyperalgesia were reversed by intrathecal baicalin administration. Additionally, baicalin significantly enhanced the effect of morphine in neuropathic animals, most likely by suppressing histone deacetylase 1 expression in the spinal dorsal horn [
 <xref rid="B176" ref-type="bibr">176</xref>]. The compound was also shown to be effective in cancer-induced bone pain: both intrathecal and oral baicalin administration reduced cytokine expression and inhibited pain-related signals as assessed by behavioral and biochemical tests [
 <xref rid="B177" ref-type="bibr">177</xref>, 
 <xref rid="B178" ref-type="bibr">178</xref>] in an animal model.
</p>
